Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

View source ↗

Summary

Clinical trial update describing general-use surveillance for Awiqli in patients with Type 1 diabetes mellitus, sponsored by Novo Nordisk A/S, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AWIQLI (INSULIN ICODEC-ABAE)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Status: RECRUITING